Megan S. Lim is Professor and Director of the Joint Division of Hematopathology, Hospital of the University of Pennsylvania and the Children’s Hospital of Philadelphia in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania. She is the Director of the Lymphoma Biology Program and Co-Leader for the Lymphoma Translational Center for Excellence at the Abramson Cancer Center. Dr. Lim received an MD from the University of Calgary and a PhD in Molecular Oncology from the University of Calgary and National Cancer Institute Lab of Pathology jointly. Dr. Lim obtained her Hematopathology fellowship training at the National Cancer Institute after which she assumed a faculty position at the University of Toronto (1998-2000) and then at the University of Utah (2000-2006). At the University of Michigan (2000-2015) she was the Director of Hematopathology and the Hematopathology Fellowship Program. She has held numerous leadership positions and served on training and education committees for the Association of Molecular Pathology and the United States Academy of Pathology. She is a member of the Board of Directors for the USCAP, Vice-Chair of the Non-Hodgkin Lymphoma Disease Committee of the Children’s Oncology Group and participates in integrated translational research in pediatric and adult lymphoma. Her research interests are focused on elucidating mechanisms involved in lymphoma pathogenesis. Her research utilizes large-scale mass spectrometry-based proteomic profiling and genomic analysis to characterize novel pathogenetic mechanisms in lymphomas.